NCI Is Being 'Flexible' With COVID-19 Clinical Trial Protocols

 
• By Brenda Sandburg
  
multiexposure background coronavirus COVID 19 infected blood sample in sample tube in hand of scientist in coronavirus research laboratory with DNA strain, coronavirus covid 19 vaccine research
NCI has revised clinical trial practices to adapt to the COVID-19 crisis
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D